Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.

Br J Cancer · 2012 · PMC3304426 · PMID 22374465

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

P <0.05 was considered significant, and P <0.01 was considered highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.